Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-13

Clinical Trial Update: Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle [Phase 3]

View source ↗

Summary

A Phase 3 trial update examining outcomes when gonadotropin doses higher than 450 IU are used in an in vitro fertilization cycle.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Clinique Ovo | Conditions: Subfertility | Phase 3 | Status: COMPLETED